# Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

> **NCT02617407** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 44 (actual)

## Conditions studied

- Dental Plaque

## Interventions

- **DRUG:** Livionex® Dental Gel
- **DRUG:** PreviDent 5000 plus/Tom's of Maine Children's toothpaste
- **DEVICE:** Kolibree Toothbrush

## Key facts

- **NCT ID:** NCT02617407
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-28
- **Primary completion:** 2020-01-27
- **Final completion:** 2020-01-27
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02617407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02617407, "Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02617407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*